C9orf72 and amyotrophic lateral sclerosis: An Italian study did not find a significantly higher proportion of NIPA1 expansion among C9orf72 positive ALS patients (3.5% = 6 patients of C9orf72 positive patients and 4.1% = 15 patients of C9orf72 negative patients).